Nudelman A - Search Results

1

The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.

Moyal L, Feldbaum N, Goldfeiz N, Rephaeli A, Nudelman A, Weitman M, Tarasenko N, Gorovitz B, Maron L, Yehezkel S, Amitay-Laish I, Lubin I, Hodak E. Moyal L, et al. Among authors: nudelman a. PLoS One. 2016 Jan 11;11(1):e0146115. doi: 10.1371/journal.pone.0146115. eCollection 2016. PLoS One. 2016. PMID: 26752418 Free PMC article.

2

The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.

Batova A, Shao LE, Diccianni MB, Yu AL, Tanaka T, Rephaeli A, Nudelman A, Yu J. Batova A, et al. Among authors: nudelman a. Blood. 2002 Nov 1;100(9):3319-24. doi: 10.1182/blood-2002-02-0567. Blood. 2002. PMID: 12384433 Free article.

3

Sequence specificity of adriamycin-DNA adducts in human tumor cells.

Cutts SM, Swift LP, Rephaeli A, Nudelman A, Phillips DR. Cutts SM, et al. Among authors: nudelman a. Mol Cancer Ther. 2003 Jul;2(7):661-70. Mol Cancer Ther. 2003. PMID: 12883039

4

The role of intracellularly released formaldehyde and butyric acid in the anticancer activity of acyloxyalkyl esters.

Nudelman A, Levovich I, Cutts SM, Phillips DR, Rephaeli A. Nudelman A, et al. J Med Chem. 2005 Feb 24;48(4):1042-54. doi: 10.1021/jm049428p. J Med Chem. 2005. PMID: 15715472

5

In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer.

Rephaeli A, Blank-Porat D, Tarasenko N, Entin-Meer M, Levovich I, Cutts SM, Phillips DR, Malik Z, Nudelman A. Rephaeli A, et al. Among authors: nudelman a. Int J Cancer. 2005 Aug 20;116(2):226-35. doi: 10.1002/ijc.21030. Int J Cancer. 2005. PMID: 15800932

6

The power and potential of doxorubicin-DNA adducts.

Cutts SM, Nudelman A, Rephaeli A, Phillips DR. Cutts SM, et al. Among authors: nudelman a. IUBMB Life. 2005 Feb;57(2):73-81. doi: 10.1080/15216540500079093. IUBMB Life. 2005. PMID: 16036566 Free article. Review.

7

Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas.

Entin-Meer M, Rephaeli A, Yang X, Nudelman A, VandenBerg SR, Haas-Kogan DA. Entin-Meer M, et al. Among authors: nudelman a. Mol Cancer Ther. 2005 Dec;4(12):1952-61. doi: 10.1158/1535-7163.MCT-05-0087. Mol Cancer Ther. 2005. PMID: 16373710

8

The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs.

Rephaeli A, Entin-Meer M, Angel D, Tarasenko N, Gruss-Fischer T, Bruachman I, Phillips DR, Cutts SM, Haas-Kogan D, Nudelman A. Rephaeli A, et al. Among authors: nudelman a. Invest New Drugs. 2006 Sep;24(5):383-92. doi: 10.1007/s10637-006-6213-1. Invest New Drugs. 2006. PMID: 16502348

9

Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.

Swift LP, Rephaeli A, Nudelman A, Phillips DR, Cutts SM. Swift LP, et al. Among authors: nudelman a. Cancer Res. 2006 May 1;66(9):4863-71. doi: 10.1158/0008-5472.CAN-05-3410. Cancer Res. 2006. PMID: 16651442

10

Mode of interaction between butyroyloxymethyl-diethyl phosphate (AN-7) and doxorubicin in MCF-7 and resistant MCF-7/Dx cell lines.

Engel D, Nudelman A, Levovich I, Gruss-Fischer T, Entin-Meer M, Phillips DR, Cutts SM, Rephaeli A. Engel D, et al. Among authors: nudelman a. J Cancer Res Clin Oncol. 2006 Oct;132(10):673-83. doi: 10.1007/s00432-006-0116-6. Epub 2006 Jul 7. J Cancer Res Clin Oncol. 2006. PMID: 16826403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters